Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inogen

5.88
-0.2600-4.23%
Post-market: 5.880.00000.00%16:20 EDT
Volume:409.31K
Turnover:2.42M
Market Cap:158.10M
PE:-5.11
High:6.19
Open:6.10
Low:5.77
Close:6.14
Loading ...

Inogen Inc (INGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ...

GuruFocus.com
·
26 Feb

Inogen Reports Strong Revenue Growth in 2024

TIPRANKS
·
26 Feb

Inogen (INGN) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
26 Feb

Inogen Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

Inogen: Q4 Earnings Snapshot

Associated Press Finance
·
26 Feb

Inogen Q4 Adj $(0.24) Beats $(0.61) Estimate, Sales $80.08M Beat $73.91M Estimate

Benzinga
·
26 Feb

Inogen reports Q4 EPS (41c) vs ($1.14) last year

TIPRANKS
·
26 Feb

BRIEF-Inogen Q4 Revenue USD 80.1 Million Vs. IBES Estimate USD 73.9 Million

Reuters
·
26 Feb

Inogen Q4 Adjusted Ebitda USD -3.6 Million

THOMSON REUTERS
·
26 Feb

Inogen Q4 Gross Margin 45.3%

THOMSON REUTERS
·
26 Feb

The Zacks Analyst Blog Highlights Fresenius Medical, Masimo, Merit Medical Systems and Inogen

Zacks
·
25 Feb

Inogen Inc expected to post a loss of 61 cents a share - Earnings Preview

Reuters
·
22 Feb

Here's Why You Should Add Inogen Stock to Your Portfolio Now

Zacks
·
06 Feb

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Zacks
·
05 Feb

Inogen Board Reshuffle with Sahney Appointment

TIPRANKS
·
04 Feb

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

THOMSON REUTERS
·
04 Feb

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Business Wire
·
04 Feb

Investors in Inogen (NASDAQ:INGN) have unfortunately lost 75% over the last five years

Simply Wall St.
·
31 Jan

Jiangsu Yuyue Medical Equipment & Supply to Take Nearly 10% Stake in Nasdaq-Listed Inogen

MT Newswires Live
·
30 Jan

Inogen’s Strategic Moves and Market Developments Lead to Hold Rating Amid Modest Near-Term Financial Impact

TIPRANKS
·
30 Jan